EcoDrugPlus

Urotensin 2 Receptor

Ensembl ID : ENSTRUG00000008902
Gene Symbol: UTS2R
1 Cross references
97 Possible Orthologues:

Utrophin

Ensembl ID : ENSTRUG00000018246
Gene Symbol: UTRN
3 Cross references
270 Possible Orthologues:

V-Akt Murine Thymoma Viral Oncogene Homolog 2

Ensembl ID : ENSTRUG00000010540
Gene Symbol: AKT2
1 Cross references
209 Possible Orthologues:

V-Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A

Ensembl ID : ENSTRUG00000008758
Gene Symbol: RELA
1 Cross references
199 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSTRUG00000031283
Gene Symbol: VEGFA
3 Cross references
201 Possible Orthologues:

Vascular Endothelial Growth Factor A-A-Like

Ensembl ID : ENSTRUG00000028504
Gene Symbol: LOC101070662
3 Cross references
180 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSTRUG00000011907
Gene Symbol: VDR
4 Cross references
388 Possible Orthologues:

Vitamin D3 Receptor B

Ensembl ID : ENSTRUG00000011576
Gene Symbol: LOC101063381
4 Cross references
392 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSTRUG00000010748
Gene Symbol: VKORC1
3 Cross references
190 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Beta-4-Like

Ensembl ID : ENSTRUG00000006633
Gene Symbol: CACNB4.1
3 Cross references
69 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-3 Subunit-Like

Ensembl ID : ENSTRUG00000009488
Gene Symbol: LOC101065009
3 Cross references
190 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSTRUG00000027528
Gene Symbol: LOC101072104
4 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).